chrX-118975393-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_001031855.3(LONRF3):c.613G>A(p.Ala205Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000499 in 1,202,208 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001031855.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LONRF3 | ENST00000371628.8 | c.613G>A | p.Ala205Thr | missense_variant | 1/11 | 1 | NM_001031855.3 | ENSP00000360690.3 | ||
LONRF3 | ENST00000304778.11 | c.613G>A | p.Ala205Thr | missense_variant | 1/10 | 1 | ENSP00000307732.7 | |||
LONRF3 | ENST00000439603.5 | c.31G>A | p.Ala11Thr | missense_variant | 1/10 | 1 | ENSP00000414519.1 | |||
LONRF3 | ENST00000481285.5 | n.613G>A | non_coding_transcript_exon_variant | 1/11 | 2 | ENSP00000435426.1 |
Frequencies
GnomAD3 genomes AF: 0.0000177 AC: 2AN: 112971Hom.: 0 Cov.: 24 AF XY: 0.0000569 AC XY: 2AN XY: 35143
GnomAD3 exomes AF: 0.0000456 AC: 7AN: 153586Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 51334
GnomAD4 exome AF: 0.00000367 AC: 4AN: 1089237Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 357149
GnomAD4 genome AF: 0.0000177 AC: 2AN: 112971Hom.: 0 Cov.: 24 AF XY: 0.0000569 AC XY: 2AN XY: 35143
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 30, 2023 | The c.613G>A (p.A205T) alteration is located in exon 1 (coding exon 1) of the LONRF3 gene. This alteration results from a G to A substitution at nucleotide position 613, causing the alanine (A) at amino acid position 205 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at